Journey from life to death by Okamoto, I

Immune Checkpoint Inhibitors for the Treatment of Unresectable Stage III Non–Small Cell Lung Cancer: Emerging Mechanisms and Perspectives by Inoue H, Okamoto I

Get full text

Molecularly targeted approaches herald a new era of non-small-cell lung cancer treatment by Kaneda H, Yoshida T, Okamoto I

Get full text

Clinical development of nintedanib for advanced non-small-cell lung cancer by Takeda M, Okamoto I, Nakagawa K

Get full text

Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer by Takeda M, Okamoto I, Nishimura Y, Nakagawa K

Get full text

Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Tria... by Tsuchiya-Kawano Y, Shiraishi Y, Kiyomi F, Okamoto I

Get full text

Exploring patient, informal carer and care professional perspectives to understand the key clinical and non-clinical care needs of those living with multiple long-term conditions (... by Simpson, G, Okamoto, I, Morrison, L, Santer, M, Farmer, A, Dambha-Miller, H

Decision-making for people with dementia and advanced kidney disease: a secondary qualitative analysis of interviews from the conservative kidney management assessment of practice... by Scott, J, Owen-Smith, A, Tonkin-Crine, S, Rayner, H, Roderick, P, Okamoto, I, Leydon, G, Caskey, F, Methven, S